eClinical Tech News

Radiopharm Theranostics has received FDA Investigational New Drug (IND) application clearance for Betabart (RV-01), a Lu177-B7H3 monoclonal antibody targeting...

Alterity Therapeutics announced positive topline data from its open-label Phase 2 clinical trial (ATH434-202) of ATH434 in individuals with...

Clearmind Medicine Inc. announced the successful initiation of a clinical trial site at Tel Aviv Sourasky Medical Center (TASMC)...

Windward Bio has launched its Phase 2 POLARIS clinical trial to assess the long-acting dosing of WIN378, an anti-TSLP...

Celcuity Inc. has initiated VIKTORIA-2, a Phase 3 clinical trial investigating gedatolisib combined with a CDK4/6 inhibitor and fulvestrant...

Revolution Medicines announced the publication of research in •Science• detailing the discovery and development of zoldonrasib, a covalent inhibitor...

Alzamend Neuro, a clinical-stage biopharmaceutical company developing treatments for Alzheimer’s, bipolar disorder, major depressive disorder, and PTSD, reported positive...

An analysis of genetic and health data from over 700,000 individuals confirms previous estimates of Autosomal Dominant Hypocalcemia type...

Invivyd has appointed Dr. Akiko Iwasaki, a renowned immunobiologist from Yale School of Medicine, to its SPEAR Study Group....

Scancell Holdings plc announced positive Phase 2 SCOPE trial data for its SCIB1/iSCIB1+ Immunobody® DNA active immunotherapies combined with...